Moving from external exposure concentration to internal dose: Duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 11-12, 2005, Pages 927-950

  Simmons, Jane Ellen ^a   Evans, Marina V ^a   Boyes, William K ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROETHYLENE;

CHEMICAL MODEL; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DOSIMETRY; ENVIRONMENTAL FACTOR; HEALTH HAZARD; HUMAN; MATHEMATICAL MODEL; METHODOLOGY; NEUROTOXICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; TARGET ORGAN; TOXICOKINETICS; ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DANGEROUS GOODS; DOSE RESPONSE; DRUG ADMINISTRATION; ENVIRONMENTAL EXPOSURE; RISK ASSESSMENT; TISSUE DISTRIBUTION;

ANIMALIA;

COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENVIRONMENTAL EXPOSURE; HAZARDOUS SUBSTANCES; HUMANS; MODELS, BIOLOGICAL; RISK ASSESSMENT; TISSUE DISTRIBUTION;

EID: 23644455995     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390590912586     Document Type: Conference Paper

References (45)

1. Abbas, R., and Fisher, J. W. 1997. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Phamacol. 147:15-30.
2. Andersen, M. E. 2003. Toxicokinetic modeling and its applications in chemical risk assessment. Toxicol. Lett. 138:9-27.
3. Andersen, M. E., Gargas, M. L., Clewell, H. J., and Severyn, K. M. 1987a. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol. 89:149-157.
4. Andersen, M. E., MacNaughton, M. G., Clewell, H. J. III, and Paustenbach, D. J. 1987b. Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model. Am. Ind. Hyg. Assoc. J. 48:335-343.
5. Andersen, M. E., Clewell, H. J., and Frederick, C. B. 1995. Applying simulation modeling to problems in toxicology and risk assessment - A short perspective. Toxicol. Appl. Pharmacol. 133:181-187.
6. Bale, A. S., Smothers, C. T., and Woodward, J. J. 2002. Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene. Br. J. Pharmacol. 137:375-383.
7. A receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 57:1199-1205.
8. Boyes, W. K., and Dyer, R.S. 1983. Pattern reversal visual evoked potentials in awake rats. Brain Res. Bulletin. 10:817-823.
9. Boyes, W. K., Bushnell, P. J., Crofton, K. M., Evans, M., and Simmons, J. E. 2000. Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario. Environ. Health Persect. 108(suppl. 2):317-322.
10. Boyes, W. K., Bercegeay, M., Ali, J. S., Krantz, T., McGee, J., Evans, M., Raymer, J. H., Bushnell, P. J., and Simmons, J. E. 2003. Dose-based duration adjustments for the effects of inhaled trichloroethylene on rat visual function. Toxicol. Sci. 76:121-130.
11. Boyes, W. K., Evans, M. V., Eklund, C., Janssen, P., and Simmons, J. E. 2005. Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model. Risk Anal.
12. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., and Beliles, R. P. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13(4):407-484.
13. Bruckner, J. V., Keys, D. A., and Fisher, J. W. 2004. The acute exposure guideline level (AEGL) program: Applications of physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A 67:1-14.
14. Bushnell, P. J. 1997. Concentration-time relationships for the effects of inhaled trichloroethylene on signal detection behavior in rats. Fundam. Appl. Toxicol. 36:30-38.
15. Clewell, H. J. III, Andersen, M. E., and Barton, H. A. 2002. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environ. Health Pespect. 110:85-93.
16. Crofton, K. M., and Zhao, X. 1997. The ototoxicity of trichloroethylene: Extrapolation and relevance of high-concentration, short-duration animal exposure data. Toxicol. Sci. 38:101-106.
17. Cruz, S. L., Mirshahi, T., Thomas, B., Balster, R. L., and Woodward, J. J. 1998. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 286:334-340.
18. Cruz, S. L., Balster, R. L., and Woodward, J. J. 2000. Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 131:1303-1308.
19. Dallas, C. E., Gallo, J. M., Ramanathan, R., Muralidhara, S., and Bruckner, J. V. 1991. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. Toxicol. Appl. Pharmacol. 110:303-314.
20. Dobrev, I. D., Andersen, M. E., and Yang, R. S. H. 2002. In silico toxicology: Simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ. Health Pespect. 110:1031-1039.
21. Easterling, M. R., Evans, M. V., and Kenyon, E. M. 2000. Comparative analysis of software for physiologically based pharmacokinetic modeling: Simulation, optimization and sensitivity analysis. Toxicol. Methods 10:203-229
22. Evans, M. V., Crank, W. D., Yang, H.-M., and Simmons, J. E. 1994. Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats. Toxicol. Appl. Pharmacol. 128:36-44.
23. Fisher, J. W. 2000. Physioloigcally based pharmacokinetic models for trichloroethylene and its oxidative metabolites. Environ. Health Perspect. 108:265-273
24. Fisher, J. W., Whittaker, T. A., Taylor, D. H., Clewell, H. J., and Andersen, M. E. 1989. Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 99:395-414.
25. Fisher, J. W., Whittaker, T. A., Taylor, D. H., Clewell, H. J., and Andersen, M. E. 1990. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 102:497-513.
26. Fisher, J. W. Gargas, M. L., Allen, B. C., and Andersen, M. E. 1991. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol. Appl. Pharmacol. 109:183-195.
27. Fisher, J. W., Mahle D., and Abbas, R. 1998. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 152:339-359.
28. Fox, D. A., and Boyes, W. K. 2001. Toxic response of the ocular and visual system. In Casarett and Doull's toxicology: The basic science of poisons. 6th ed., ed. C. D. Klaassen, pp. 565-595. New York: McGraw-Hill.
29. Friberg, L., Kylin, B., and Nystrom, A. 1953. Toxicities of trichloroethylene and tetrachloroethylene and Fujiwara's pyridine alkali reaction. Acta Pharmacal. Toxicol. 9:303-312.
30. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:87-99.
31. Keys, D. A., Bruckner, J. V., Muralidhara, S. M., and Fisher, J. W. 2003. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene. Toxicol. Sci. 76:35-50.
32. Krishnan, K., and Andersen, M. E. 2001. Physiologically based pharmacokinetic modeling in toxicology. In Principles and methods of toxicology, 4th ed., ed. A. W. Hayes, pp. 193-241. Philadelphia: Taylor & Francis.
33. Krishnan, K., Haddad, S., and Pelekis, M. 1995. A simple index for representing the discrepancy between simulations of physiological pharmacokinetic models and experimental data. Toxicol. Ind. Health 11:413-422.
34. Lipscomb, J. C., Fisher, J. W., Confer, P. D., and Byczkowski, J. Z. 1998. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. Toxicol. Appl. Pharmacol. 152, 376-387.
35. McGee, J. K., Evans, M. V., and Crank, W. D. 1995. A versatile gas uptake inhalation system used in pharmacokinetic and metabolic studies of volatile organic compounds. Toxicol. Methods 5:199-212.
36. Medinsky, M. A., and Valentine, J. L. 2001. Toxicokinetics. In Casarett and Doull's toxicology: The basic science of poisons, 6th ed., ed. C. D. Klaassen, pp. 225-237. New York: McGraw-Hill.
37. National Research Council. 2001. Standard operating procedures for developing acute exposure guideline levels of hazardous chemicals. Washington, DC: National Academy Press.
38. Ramsey, J. C., and Andersen, M. E. 1984. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73:159-175.
39. Simmons, J. E., Boyes, W. K., Bushnell, P. J., Raymer, J., Limsakun, T., McDonald, A., and Simmons, J. E. 2002. A physiologically-based pharmacokinetic model for trichloroethylene with specificity for the Long-Evans rat. Toxicol. Sci. 69:3-15.
40. ten Berge, W. F., Zwart, A., and Appelman, L. M. 1986. Concentration-time mortality response relationship of irritant and systemically acting vapours and gases. J. Hazard. Mater. 13:301-309.
41. Thrall, K. D., and Poet, T. S. 2000. Determination of biokinetic interactions in chemical Mixtures using real-time breath analysis and physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A 59:653-670.
42. Tillar, R., Shafer, T. J., and Woodward, J. J. 2002. Toluene inhibits voltage-sensitive calcium channels expressed in pheochromocytoma cells. Neurochem. Int. 41:391-397.
43. U.S. Environmental Protection Agency. 2002. National-scale air toxics assessment, http://www.epa.gov/ttn/atw/nata/natasaov.html, accessed May 2002.
44. Vernon, R. J., and Ferguson, R. K. 1969. Effects of trichloroethylene on visual-motor performance. Arch. Environ. Health 18:894-900.
45. Warren, D. A., Muralidhara, S., and Bruckner, J. V. 1994. Strain differences in the blood and tissue levels of trichloroethylene following exposure of Sprague-Dawley and Fischer 344 (F344) rats. Toxicologist 14:282 (abstr. 1083).